S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
NYSE:CLVT

Clarivate (CLVT) Stock Price, News & Analysis

$7.43
-0.03 (-0.40%)
(As of 04:37 PM ET)
Today's Range
$7.42
$7.59
50-Day Range
$7.01
$9.44
52-Week Range
$6.07
$10.03
Volume
2.77 million shs
Average Volume
4.04 million shs
Market Capitalization
$4.96 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

Clarivate MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
7.7% Upside
$8.00 Price Target
Short Interest
Bearish
9.18% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.70mentions of Clarivate in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.06%
From $0.62 to $0.67 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.83 out of 5 stars

Computer And Technology Sector

520th out of 587 stocks

Data Processing & Preparation Industry

49th out of 57 stocks

CLVT stock logo

About Clarivate Stock (NYSE:CLVT)

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

CLVT Stock Price History

CLVT Stock News Headlines

$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
Comparing Sterling Check (NASDAQ:STER) & Clarivate (NYSE:CLVT)
CLVT Oct 2024 5.000 put
CLVT Jul 2024 7.500 put
the most reliable asset on earth is making a comeback
Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.
Clarivate Reveals Top 100 Global Innovators 2024
Exor N.V.: Clarivate and Exor sign agreement
Clarivate and Exor sign agreement
The Analyst Landscape: 5 Takes On Clarivate
See More Headlines
Receive CLVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clarivate and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
3/28/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Fax
N/A
Employees
12,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$10.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+6.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
9 Analysts

Profitability

Net Income
$-911,200,000.00
Pretax Margin
-38.52%

Debt

Sales & Book Value

Annual Sales
$2.63 billion
Cash Flow
$1.86 per share
Book Value
$6.93 per share

Miscellaneous

Free Float
514,573,000
Market Cap
$5.02 billion
Optionable
Optionable
Beta
1.25
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Jonathan Gear (Age 53)
    CEO & Director
    Comp: $1.3M
  • Mr. Jonathan M. Collins (Age 44)
    Executive VP & CFO
    Comp: $1.96M
  • Mr. Gordon Samson (Age 58)
    President of Intellectual Property
    Comp: $1.02M
  • Mr. Michael Easton (Age 51)
    Senior VP of Finance & Chief Accounting Officer
  • Mr. William E. Graff
    Chief Information Officer
  • Mr. Mark J. Donohue
    Head of Investor Relations
  • Ms. Melanie D. Margolin J.D. (Age 52)
    Chief Legal Officer
  • Ms. Tabita Andersson
    Senior Vice President of Communications & Brand
  • Ms. Julia M. Wilson (Age 61)
    Chief People Officer
  • Mr. Richard C. Finch
    Global Head of Life Sciences Consulting Services

CLVT Stock Analysis - Frequently Asked Questions

Should I buy or sell Clarivate stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clarivate in the last year. There are currently 3 sell ratings, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CLVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLVT, but not buy additional shares or sell existing shares.
View CLVT analyst ratings
or view top-rated stocks.

What is Clarivate's stock price target for 2024?

9 brokerages have issued 1-year target prices for Clarivate's stock. Their CLVT share price targets range from $6.00 to $10.00. On average, they anticipate the company's share price to reach $8.00 in the next year. This suggests a possible upside of 7.7% from the stock's current price.
View analysts price targets for CLVT
or view top-rated stocks among Wall Street analysts.

How have CLVT shares performed in 2024?

Clarivate's stock was trading at $9.26 at the beginning of 2024. Since then, CLVT stock has decreased by 19.8% and is now trading at $7.43.
View the best growth stocks for 2024 here
.

Are investors shorting Clarivate?

Clarivate saw a decrease in short interest during the month of February. As of February 29th, there was short interest totaling 34,360,000 shares, a decrease of 10.7% from the February 14th total of 38,480,000 shares. Based on an average daily trading volume, of 4,300,000 shares, the short-interest ratio is currently 8.0 days. Approximately 9.3% of the company's stock are short sold.
View Clarivate's Short Interest
.

When is Clarivate's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our CLVT earnings forecast
.

How were Clarivate's earnings last quarter?

Clarivate Plc (NYSE:CLVT) released its earnings results on Tuesday, February, 27th. The company reported $0.21 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.21. The firm earned $683.70 million during the quarter, compared to analysts' expectations of $687.80 million. Clarivate had a positive trailing twelve-month return on equity of 9.95% and a negative net margin of 34.66%. The business's revenue for the quarter was up 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.20 EPS.

What ETF holds Clarivate's stock?

iShares MSCI USA Size Factor ETF holds 68,505 shares of CLVT stock, representing 0.20% of its portfolio.

What guidance has Clarivate issued on next quarter's earnings?

Clarivate updated its FY24 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of $0.70 to $0.80 for the period, compared to the consensus earnings per share estimate of $0.85. The company issued revenue guidance of $2.57 billion to $2.67 billion, compared to the consensus revenue estimate of $2.69 billion.

Who are Clarivate's major shareholders?

Clarivate's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Exor N.V. (9.90%), Generation Investment Management LLP (4.42%), Baupost Group LLC MA (3.84%), Glenview Capital Management LLC (3.71%), Vanguard Group Inc. (1.24%) and Vanguard Group Inc. (1.23%). Insiders that own company stock include Andrew Miles Snyder, Blucher Sheryl G Von, Corp Onex, James Gordon Samson, Jeff Roy, Mukhtar Ahmed, Richard Hanks and Richard Roedel.
View institutional ownership trends
.

How do I buy shares of Clarivate?

Shares of CLVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CLVT) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners